| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.1M | -49.4% |
| Cost of Revenue | $12.8M | -66.3% |
| R&D Expense | $58.9M | -26.5% |
| SG&A Expense | $53.3M | +2.1% |
| Operating Income | -$68.1M | -95.1% |
| Pre-tax Income | -$76.2M | -128.6% |
| Income Tax | $69K | -75.0% |
| Net Income | -$76.2M | -127.0% |
| EPS (Basic) | -$1.12 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $65.1M | -42.9% |
| Accounts Receivable | $10.0M | -68.5% |
| Inventory | $2.7M | +32.3% |
| Current Assets | $93.5M | -42.6% |
| Total Assets | $136.6M | -45.5% |
| Current Liabilities | $35.8M | -27.0% |
| Total Liabilities | $49.9M | -52.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$52.6M | -566.5% |
| Capital Expenditures | $4.4M | -46.8% |
| Investing Cash Flow | -$4.9M | +64.2% |
| Financing Cash Flow | $8.2M | +1520.3% |
| Free Cash Flow | -$57.1M | -2016.6% |
| -119.6% |
| EPS (Diluted) | -$1.12 | -119.6% |
| Stockholders' Equity |
| $86.6M |
| -40.2% |